/Companies

ATB Therapeutics

Founded 2018 · 38 employees on LinkedIn · 9 known investors

Find your way into ATB Therapeutics

Sign up to see every warm intro you have to ATB Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the ATB Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

ATB Therapeutics is a biotech company developing bispecific antibody therapies and related immunological treatments. The company operates in the preclinical and clinical stage biotechnology space.

Founders & leadership

DMDr. Mark Throsby
Dr. Mark ThrosbyChief Executive Officer

Investors · 9

Also in the syndicate · 2

SFPIMV-Bio Ventus

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Frequently asked questions

What does ATB Therapeutics do?
ATB Therapeutics is a biotech company developing bispecific antibody therapies and related immunological treatments. The company operates in the preclinical and clinical stage biotechnology space.
Who are ATB Therapeutics's investors?
ATB Therapeutics's investors include MRL Ventures Fund, V-Bio Ventures, VIVES Partners, EQT Life Sciences, Sambrinvest, Wallonie Entreprendre, EQT.